These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1167 related items for PubMed ID: 18021365
1. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S, Majumdar S. Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365 [Abstract] [Full Text] [Related]
3. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Mazumdar T, Anam K, Ali N. Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644 [Abstract] [Full Text] [Related]
4. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK, Naskar K, De T. Eur J Immunol; 2009 Aug 12; 39(8):2146-60. PubMed ID: 19593771 [Abstract] [Full Text] [Related]
5. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, Flesch IE, Kroczek RA. Proc Natl Acad Sci U S A; 2002 Apr 30; 99(9):6181-6. PubMed ID: 11972057 [Abstract] [Full Text] [Related]
6. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation. Datta N, Mukherjee S, Das L, Das PK. Eur J Immunol; 2003 Jun 30; 33(6):1508-18. PubMed ID: 12778468 [Abstract] [Full Text] [Related]
7. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Bhattacharya P, Dey R, Dagur PK, Kruhlak M, Ismail N, Debrabant A, Joshi AB, Akue A, Kukuruga M, Takeda K, Selvapandiyan A, McCoy JP, Nakhasi HL. Infect Immun; 2015 Oct 30; 83(10):3800-15. PubMed ID: 26169275 [Abstract] [Full Text] [Related]
8. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge. Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A. J Immunol; 2011 Dec 15; 187(12):6417-27. PubMed ID: 22079980 [Abstract] [Full Text] [Related]
9. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses. Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, Dube A. J Antimicrob Chemother; 2012 Feb 15; 67(2):440-3. PubMed ID: 22121191 [Abstract] [Full Text] [Related]
10. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. Bhattacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, Majumdar S. J Infect Dis; 2002 Jun 15; 185(12):1704-8. PubMed ID: 12085314 [Abstract] [Full Text] [Related]
12. Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide. Bhattacharjee S, Gupta G, Bhattacharya P, Adhikari A, Majumdar SB, Majumdar S. Indian J Exp Biol; 2009 Jun 01; 47(6):489-97. PubMed ID: 19634715 [Abstract] [Full Text] [Related]
13. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. Schrum S, Probst P, Fleischer B, Zipfel PF. J Immunol; 1996 Oct 15; 157(8):3598-604. PubMed ID: 8871660 [Abstract] [Full Text] [Related]
14. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. Kim JJ, Nottingham LK, Sin JI, Tsai A, Morrison L, Oh J, Dang K, Hu Y, Kazahaya K, Bennett M, Dentchev T, Wilson DM, Chalian AA, Boyer JD, Agadjanyan MG, Weiner DB. J Clin Invest; 1998 Sep 15; 102(6):1112-24. PubMed ID: 9739045 [Abstract] [Full Text] [Related]
15. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection. Bimal S, Sinha S, Singh SK, Narayan S, Kumar V, Verma N, Ranjan A, Sinha PK, Das VN, Pandey K, Kar SK, Das P. Exp Parasitol; 2012 Jul 15; 131(3):274-82. PubMed ID: 22580024 [Abstract] [Full Text] [Related]
16. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. Sato N, Kuziel WA, Melby PC, Reddick RL, Kostecki V, Zhao W, Maeda N, Ahuja SK, Ahuja SS. J Immunol; 1999 Nov 15; 163(10):5519-25. PubMed ID: 10553079 [Abstract] [Full Text] [Related]
17. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. Karpus WJ, Kennedy KJ. J Leukoc Biol; 1997 Nov 15; 62(5):681-7. PubMed ID: 9365124 [Abstract] [Full Text] [Related]
18. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. Reiner NE. J Immunol; 1987 Mar 15; 138(6):1919-25. PubMed ID: 3493291 [Abstract] [Full Text] [Related]
19. T helper 1 and T helper 2 cells respond differentially to chemokines. Siveke JT, Hamann A. J Immunol; 1998 Jan 15; 160(2):550-4. PubMed ID: 9551886 [Abstract] [Full Text] [Related]
20. Inhibition of Th1- and enhancement of Th2-initiating cytokines and chemokines in trichosanthin- treated macrophages. Xu W, Hou W, Yao G, Ji Y, Yeh M, Sun B. Biochem Biophys Res Commun; 2001 Jun 01; 284(1):168-72. PubMed ID: 11374886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]